Stock Scorecard



Stock Summary for Eyenovia Inc (EYEN) - $1.17 as of 5/5/2025 3:03:40 PM EST

Total Score

4 out of 30

Safety Score

15 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for EYEN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for EYEN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for EYEN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for EYEN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for EYEN (15 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 1
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for EYEN

Eyenovia Provides Development Update on Optejet User Filled Device ( UFD ) - Eyenovia ( NASDAQ:EYEN ) 4/10/2025 11:00:00 AM
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - Eyenovia ( NASDAQ:EYEN ) 3/20/2025 11:00:00 AM
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq 3/20/2025 11:00:00 AM
Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Eyenovia ( NASDAQ:EYEN ) 2/26/2025 8:22:00 PM
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - Eyenovia ( NASDAQ:EYEN ) 2/24/2025 12:00:00 PM
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives 2/24/2025 12:00:00 PM
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - Eyenovia ( NASDAQ:EYEN ) 2/5/2025 12:00:00 PM
Deal Dispatch: TD Bank To Sell Charles Schwab Stake? - Constellation Energy ( NASDAQ:CEG ) , Walt Disney ( NYSE:DIS ) 1/10/2025 5:25:00 PM
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - Eyenovia ( NASDAQ:EYEN ) 1/6/2025 12:00:00 PM
Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Alset ( NASDAQ:AEI ) , Ambow Education Holding ( AMEX:AMBO ) 12/31/2024 10:33:00 AM

Financial Details for EYEN

Company Overview

Ticker EYEN
Company Name Eyenovia Inc
Country USA
Description Eyenovia, Inc., a clinical-stage ophthalmic company, is dedicated to developing therapies based on its proprietary Micro-Dose Matrix Printing Platform (MAP) technology. The company is headquartered in New York, New York.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date 6/12/2025

Stock Price History

Last Day Price 1.17
Price 4 Years Ago 320.00
Last Day Price Updated 5/5/2025 3:03:40 PM EST
Last Day Volume 26,069
Average Daily Volume 51,748
52-Week High 124.80
52-Week Low 0.85
Last Price to 52 Week Low 37.65%

Valuation Measures

Trailing PE N/A
Industry PE 32.04
Sector PE 37.03
5-Year Average PE -206.76
Free Cash Flow Ratio 1.56
Industry Free Cash Flow Ratio 19.19
Sector Free Cash Flow Ratio 29.42
Current Ratio Most Recent Quarter 0.17
Total Cash Per Share 0.75
Book Value Per Share Most Recent Quarter -8.69
Price to Book Ratio 36.17
Industry Price to Book Ratio 7.60
Sector Price to Book Ratio 21.93
Price to Sales Ratio Twelve Trailing Months 56.28
Industry Price to Sales Ratio Twelve Trailing Months 101.19
Sector Price to Sales Ratio Twelve Trailing Months 28.34
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 2,830,600
Market Capitalization 3,311,802
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -82.75%
Reported EPS 12 Trailing Months -59.81
Reported EPS Past Year 0.00
Reported EPS Prior Year -4.24
Net Income Twelve Trailing Months -58,851,112
Net Income Past Year -49,818,433
Net Income Prior Year -27,261,096
Quarterly Revenue Growth YOY 985.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months -29,343.00%

Balance Sheet

Total Cash Most Recent Quarter 2,121,463
Total Cash Past Year 2,121,463
Total Cash Prior Year 14,849,057
Net Cash Position Most Recent Quarter -19,652
Net Cash Position Past Year -6,835,768
Long Term Debt Past Year 8,957,231
Long Term Debt Prior Year 8,957,231
Total Debt Most Recent Quarter 2,141,115
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year -13,095,952
Total Stockholder Equity Prior Year 8,999,094
Total Stockholder Equity Most Recent Quarter -13,095,952

Free Cash Flow

Free Cash Flow Twelve Trailing Months -26,387,506
Free Cash Flow Per Share Twelve Trailing Months -9.32
Free Cash Flow Past Year -30,282,458
Free Cash Flow Prior Year -27,807,076

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.09
MACD Signal -0.14
20-Day Bollinger Lower Band -2.22
20-Day Bollinger Middle Band 3.11
20-Day Bollinger Upper Band 8.44
Beta 0.76
RSI 43.49
50-Day SMA 31.69
150-Day SMA 121.43
200-Day SMA 164.13

System

Modified 5/5/2025 11:35:23 PM EST